QNCX Chart
See on advanced chart >
About
Quince Therapeutics, Inc. was incorporated in Delaware on June 20, 2012. The company is a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what they believe to be a key underlying cause of Alzheimer's...
Read More
- HighlightA biopharmaceutical company that advancing innovative precision therapeutics for debilitating and rare diseases
- ExchangeNASDAQ
- Listing Date05/09/2019
- Established Date06/20/2012
- Full-time Employees32
- Address601 Gateway Blvd Ste. 1250 South San Francisco California
- Tel1-415-9105717
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology